Medically-Graded Honey Supplementation Formula To Preterm Infants
Honey
Randomized Controlled Trial on Medically-Graded Honey Supplementation Formula (As a Prebiotic) To Preterm Infants
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Honey is a natural product that contains multiple nutrients; it is composed of fructose, glucose and fructooligosaccharides that can potentially serve prebiotic functions. It also contains more than 180 substances including amino acids, vitamins, minerals and enzymes. Investigators hypothesized that supplementation of enteral feeds with honey would produce a bifidogenic effect and stimulate the immune response in preterm infants. Investigators randomly assigned subjects to 4 groups receiving 0, 5, 10 and 15 grams of honey daily for 2 weeks and measured their effect on stool colonization, systemic immune parameters and anthropometric measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Jan 2011
Typical duration for early_phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 3, 2016
CompletedFirst Posted
Study publicly available on registry
February 10, 2016
CompletedFebruary 10, 2016
February 1, 2016
3.2 years
February 3, 2016
February 9, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
The presence of Bifidobacterium bifidum and Lactobacillus spp in Stool
Stool culture/ Gram Stain and quantitative real time PCR were used to for this outcome.
Two weeks
Secondary Outcomes (4)
CD4 and CD8 concentration in the serum
2 weeks
Change in Weight (gram)
Baseline and 2 weeks
Change in crown-heel length (cm)
Baseline and 2 weeks
Change in head circumference (cm)
Baseline and 2 weeks
Study Arms (4)
Control 0
PLACEBO COMPARATORNo Intervention. This group received Premature Milk Formula. This group did not receive any Medically-Graded Honey.
Group 1
EXPERIMENTALThis group received Premature Milk Formula. This group received Medically-Graded Honey (dose = 5 gram/day) for 2 weeks
Group 2
EXPERIMENTALThis group received Premature Milk Formula. This group received Medically-Graded Honey (dose = 10 gram/day) for 2 weeks
Group 3
EXPERIMENTALThis group received Premature Milk Formula. This group received Medically-Graded Honey (dose = 15 gram/day) for 2 weeks
Interventions
Honey added to the baby formula once a day for 2 weeks.
Enteral feeds were provided to subjects of all groups using premature milk formula as per routine nutritional management in the neonatal intensive care unit.
Eligibility Criteria
You may qualify if:
- preterm infants with gestational age ≤ 34 weeks
- postnatal age \> 3 days
- no previous enteral feeding, and
- parental wish to use milk formula with no intention to use breast milk or breastfeed.
You may not qualify if:
- infants with major chromosomal abnormalities
- Infant with major congenital anomalies of the cardiovascular, pulmonary or central nervous system; including neuromuscular disorders and neural tube defects
- infants with intestinal atresia, tracheoesophageal fistulas, omphalocele, gastroschisis, and other major congenital GI anomalies, and
- infants with sepsis, either before or during enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Related Publications (5)
Boyar V, Handa D, Clemens K, Shimborske D. Clinical experience with Leptospermum honey use for treatment of hard to heal neonatal wounds: case series. J Perinatol. 2014 Feb;34(2):161-3. doi: 10.1038/jp.2013.158.
PMID: 24476663RESULTEteraf-Oskouei T, Najafi M. Traditional and modern uses of natural honey in human diseases: a review. Iran J Basic Med Sci. 2013 Jun;16(6):731-42.
PMID: 23997898RESULTEzz El-Arab AM, Girgis SM, Hegazy EM, Abd El-Khalek AB. Effect of dietary honey on intestinal microflora and toxicity of mycotoxins in mice. BMC Complement Altern Med. 2006 Mar 14;6:6. doi: 10.1186/1472-6882-6-6.
PMID: 16533410RESULTKapiki A, Costalos C, Oikonomidou C, Triantafyllidou A, Loukatou E, Pertrohilou V. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum Dev. 2007 May;83(5):335-9. doi: 10.1016/j.earlhumdev.2006.07.003. Epub 2006 Sep 14.
PMID: 16978805RESULTAly H, Said RN, Wali IE, Elwakkad A, Soliman Y, Awad AR, Shawky MA, Alam MSA, Mohamed MA. Medically Graded Honey Supplementation Formula to Preterm Infants as a Prebiotic: A Randomized Controlled Trial. J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):966-970. doi: 10.1097/MPG.0000000000001597.
PMID: 28379925DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics
Study Record Dates
First Submitted
February 3, 2016
First Posted
February 10, 2016
Study Start
January 1, 2011
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
February 10, 2016
Record last verified: 2016-02